Yahoo
NSE - Delayed Quote INR

Lincoln Pharmaceuticals Limited (LINCOLN.NS)

520.85 +7.15 (+1.39%)
At close: 3:30:00 PM GMT+5:30
View in AlphaSpace Currency in INR All numbers in thousands
Financial statements have been upgraded
A new layout with more detail in every statement.
TTM
3/31/2026
3/31/2025
3/31/2024
3/31/2023
Cash Flow from Operating Activities, Indirect
937,927 1,063,595 930,155 632,166 392,619
Cash Flow from Investing Activities
-917,304 -984,069 -789,474 -573,410 -366,426
Cash Flow from Financing Activities
-10,583 1,589 -64,015 -51,804 -45,013
Cash and Cash Equivalents, End of Period
212,857 215,253 134,138 57,472 50,520
Cash Flow, Supplemental
Free Cash Flow to Firm
382,943.80 704,222.72 635,529.24 391,689.88 561,892.44
Capital Expenditure, Calculated
538,527 260,401 192,442 396,130 142,820
Issuance of Capital Stock
0 0 0 0 0
Repurchase of Capital Stock
0 0 0 0 0
Free Cash Flow to Cash Flow from Operating Activities
0.41 0.73 0.77 0.49 0.79
3/31/2023 - 12/17/2015

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: